Financials
- Market Capitalization 4.49 M
- Employee 1
- Founded 2020
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4981 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 0.37 USD | +5.71% | +2.78% | +8.82% | -79.44% | 4.74 M USD | ||
| 4986 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.21 USD | +4.31% | +11.01% | -4.72% | -62.54% | 4.60 M USD | ||
| 4993 | FBLG FibroBiologics, Inc. - Common Stock | 0.85 USD | -1.16% | +3.66% | -2.30% | +23.19% | 4.43 M USD | ||
| 5002 | ENSC Ensysce Biosciences, Inc. - Common Stock | 0.29 USD | +3.57% | +3.57% | +7.41% | -24.18% | 4.26 M USD |